News Breaks |
|
|
| September 13, 2012 |
| 11:05 EDT |  | JNJ, SNY | FDA says topical pain relievers may cause burns The FDA warned that some consumers have reported receiving serious skin injuries while using certain over-the-counter pain relievers applied to the skin to relieve mild muscle and joint pain. According to the agency, there have been 43 reported cases of burns associated with the use of OTC topical muscle and joint pain relievers containing the active ingredients menthol, methyl salicylate and capsaicin. The injuries have ranged from mild to severe chemical burns with use of Sanofi's (SNY) Icy Hot and Johnson & Johnson's (JNJ) Bengay, among others, the FDA said in today's press release. |
|
|
News For JNJ;SNY From The Last 14 Days Check below for free stories on JNJ;SNY the last two weeks. |
|
|
| May 20, 2013 |
| 17:26 EDT |  | SNY | Regeneron, Genentech, Sanofi enter into 'Zaltrap agreement'
Subscribe for More Information |
|
| 11:27 EDT |  | SNY | Appeals court reverses, remands patent ruling in Sanofi suit against Mylan, Teva
Subscribe for More Information |
|
| May 17, 2013 |
| 08:03 EDT |  | SNY | Sanofi reports positive topline results from pivotal Phase III Jakarta study
Subscribe for More Information |
|
| 06:19 EDT |  | JNJ | J&J to end sales of of metal-on-metal hip replacements, Bloomberg reports
Subscribe for More Information |
|
| 05:18 EDT |  | SNY | Sanofi says JAK2 inhibitor for myelofibrosis met primary endpoint
Subscribe for More Information |
|
| May 15, 2013 |
| 16:51 EDT |  | JNJ | FDA approves Simponi to treat ulcerative colitis
Subscribe for More Information |
|
| 15:16 EDT |  | SNY | Sanofi systemic sclerosis treatment designated for orphan drug status
Subscribe for More Information |
|
| 05:39 EDT |  | SNY | Sanofi, Regeneron announce patient enrollment in two Phase 3 trials
Subscribe for More Information |
|
| May 13, 2013 |
| 09:44 EDT |  | SNY | Several companies reportedly interested in buying Adcock Ingram, Globes says
Subscribe for More Information |
|
| 07:30 EDT |  | SNY | TechConnect to host a summit 2013 National Innovation Summit is being held in Washington, D.C. on May 12-16. |
| |
| May 10, 2013 |
| 11:48 EDT |  | SNY, JNJ | Drugmakers to face pressure on U.S. prices, Reuters says
Subscribe for More Information |
|
| 06:16 EDT |  | JNJ | Obesity surgery booming in India, Bloomberg reports
Subscribe for More Information |
|
| May 9, 2013 |
| 17:09 EDT |  | JNJ | Johnson & Johnson deal to settle sales practices probe stalls, WSJ reports Johnson & Johnson's $2.2B settlement with the Justice Department related to its promotion of certain drugs is on hold as the company is looking to avoid language in the agreement that could make it vulnerable to private lawsuits, reports The Wall Street Journal, citing people familiar with the talks. Reference Link |
|
| 09:51 EDT |  | JNJ | J&J unit says first patient enrolled in reMARQable study
Subscribe for More Information |
|
| May 8, 2013 |
| 07:38 EDT |  | JNJ | BofA/Merrill's medical tech analyst hold an analyst/industry conference call
Subscribe for More Information |
|
| May 6, 2013 |
| 11:29 EDT |  | JNJ | J&J cosmetics license revoked at Mumbai plant, Reuters says
Subscribe for More Information |
|
| 07:49 EDT |  | SNY | Bernstein's global pharmaceuticals analyst has analyst/industry conference call
Subscribe for More Information |
|
| 07:24 EDT |  | JNJ | Drug companies attempt to make painkillers that can't be abused, WSJ reports
Subscribe for More Information |
|
|
|
|
|